{"disease":{"id":"atopic-dermatitis-and-related-conditions","name":"atopic dermatitis and related conditions"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04240522","title":"Prospective Longitudinal Observational Research in Atopic Dermatitis","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"University of Zurich","has_results":false},{"nct_id":"NCT06361992","title":"Efficacy and Safety of Blue Cap for the Treatment of Atopic Dermatitis in Children","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":58,"lead_sponsor_name":"Catalysis SL","has_results":false},{"nct_id":"NCT03619161","title":"Bleach vs. Bubbles: Assessing the Impact of the Bathroom Environment on Eczema","phase":"NA","overall_status":"COMPLETED","enrollment_count":58,"lead_sponsor_name":"University of North Carolina, Chapel Hill","has_results":false},{"nct_id":"NCT03293030","title":"Immunogenetic Profiling of Dupilumab for the Treatment of Atopic Dermatitis","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":17,"lead_sponsor_name":"University of California, San Francisco","has_results":true}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}